Filing Details
- Accession Number:
- 0001209191-17-047862
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-07 16:02:33
- Reporting Period:
- 2017-08-04
- Filing Date:
- 2017-08-07
- Accepted Time:
- 2017-08-07 16:02:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1566373 | Spring Bank Pharmaceuticals Inc. | SBPH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1296999 | David Arkowitz | C/O Spring Bank Pharmaceuticals, Inc. 86 South Street Hopkinton MA 01748 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-04 | 200 | $12.25 | 17,086 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-04 | 2,300 | $12.24 | 19,386 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
